Literature DB >> 33244664

The anti-inflammatory properties of Acanthus Ebracteatus, Barleria Lupulina and Clinacanthus Nutans: a systematic review.

Naomi Temitope Olubusola Ilori1, Crystal Xiao-Qi Liew2, Chee-Mun Fang3.   

Abstract

This appraisal is comprised of the inflammatory studies that have been conducted on Clinacanthus nutans, Acanthus ebracteatus, and Barleria lupulina. The review aims to provide a comprehensive evaluation of the supporting and contradictory evidence on each plants' anti-inflammatory properties, whilst addressing the gaps in the current literature. The databases used to obtain relevant studies were Google Scholar, ResearchGate, PubMed and Nusearch (University of Nottingham). A total of 13 articles were selected for this review. A. ebracteatus was found to suppress neutrophil migration and weakly inhibits chronic inflammatory cytokines. Furthermore, B. lupulina and C. nutans were shown to possess very similar anti-inflammatory properties. The studies on C. nutans indicated that its anti-inflammatory effect is strongly related to the inhibition of toll-like receptor 4 (TLR4). Moreover, several phytoconstituents isolated from B. lupulina were shown to activate the anti-inflammatory Nrf2 pathway. Overall, all the studies have provided evidence to support the use of these plants as anti-inflammatory herbal remedies. However, their exact mechanism of action and the responsible phytoconstituents are yet to be established.

Entities:  

Keywords:  Acanthus ebracteatus; Anti-inflammatory; Barleria lupulina; Clinacanthus nutans

Mesh:

Substances:

Year:  2020        PMID: 33244664     DOI: 10.1007/s11033-020-06025-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  1 in total

1.  New Insights on Acanthus ebracteatus Vahl: UPLC-ESI-QTOF-MS Profile, Antioxidant, Antimicrobial and Anticancer Activities.

Authors:  Opeyemi Joshua Olatunji; Oladipupo Odunayo Olatunde; Titilope John Jayeoye; Sudarshan Singh; Sirinporn Nalinbenjapun; Sasikarn Sripetthong; Warangkana Chunglok; Chitchamai Ovatlarnporn
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.